Toggle Main Menu Toggle Search

Open Access padlockePrints

Health care access of thyroid disease patients in Serbia during the COVID-19 pandemic

Lookup NU author(s): Dr Petros Perros, Professor Miodrag Stojkovic

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2022, The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE). Purpose: The aim of this study was to assess the impact of repurposing health care facilities in response to COVID-19 on the access of patients with thyroid disease to health care. Methods: This study consisted of a web-based survey. The survey was anonymous and consisted of forty questions. Results: This survey included 206 respondents. 91.3% of the respondents had health insurance through the Republic Fund of Health Insurance, 9.7% had private or both health insurances, and 3.4% did not have any health insurance. A significant proportion of respondents (60.4%) had to switch from public to private health care to reach a physician and 73.8% had to switch from public to private laboratories. For the 91.9%, this was perceived as a financial burden. Before the pandemic, 83.1% of respondents reported regular follow-up by physicians, which decreased to 44.9% during the pandemic (p < 0.01). 76.3% of the respondents regarded that their thyroid disease was managed optimally before the pandemic, while this figure declined to only 48% during the pandemic (p < 0.01). Conclusions: The COVID-19 pandemic disrupted the medical care of thyroid patients in Serbia. For the patients treated in the public health care system, access to general practice was hindered, while access to specialist care was disrupted. It led to a switch from public to private health care, which was perceived as a financial burden for almost all the respondents. However, private health care proved to be an important safety net when the public system was overwhelmed.


Publication metadata

Author(s): Zarkovic M, Perros P, Ciric J, Beleslin B, Stojanovic M, Stojkovic M, Miletic M, Janic T

Publication type: Article

Publication status: Published

Journal: Journal of Endocrinological Investigation

Year: 2022

Volume: 45

Pages: 1521–1526

Print publication date: 01/08/2022

Online publication date: 24/03/2022

Acceptance date: 14/03/2022

ISSN (print): 0391-4097

ISSN (electronic): 1720-8386

Publisher: Springer Nature

URL: https://doi.org/10.1007/s40618-022-01787-6

DOI: 10.1007/s40618-022-01787-6

PubMed id: 35325447


Altmetrics

Altmetrics provided by Altmetric


Share